Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.22B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$504M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$335M |
| 4 |
Bank of America
BAC
|
+$324M |
| 5 |
TSMC
TSM
|
+$297M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.62B |
| 2 |
Meta Platforms (Facebook)
META
|
+$471M |
| 3 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$396M |
| 4 |
NVIDIA
NVDA
|
+$391M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 90.25% |
| 2 | Technology | 2.31% |
| 3 | Consumer Discretionary | 1.61% |
| 4 | Financials | 1.35% |
| 5 | Healthcare | 1.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11376
PUT
Mistras Group
MG
$613M
| $79.3K | ﹤0.01% |
+11,700
| New | +$64.1K |
|
|
TCON
11377
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
| $79.1K | ﹤0.01% |
+2,094
| New | +$68.6K |
|
|
PLM
11378
DELISTED
PolyMet Mining Corp.
PLM
| $79.1K | ﹤0.01% |
+36,796
| New | +$91.4K |
|
11379
PUT
CS Disco
LAW
$286M
| $79K | ﹤0.01% |
+11,900
| New | +$84.6K |
|
11380
Deswell Industries
DSWL
$47.8M
| $78.9K | ﹤0.01% |
29,664
+10,260
| +53% | +$30.4K |
|
|
RBOT
11381
DELISTED
Vicarious Surgical
RBOT
| $78.8K | ﹤0.01% |
+1,157
| New | +$90K |
|
11382
CALL
Rush Street Interactive
RSI
$3.03B
| $78.7K | ﹤0.01% |
25,300
-61,500
| -71% | -$236K |
|
|
UXIN
11383
PUT
Uxin Ltd
UXIN
$257M
| $78.6K | ﹤0.01% |
3,510
+1,570
| +81% | +$46.1K |
|
11384
Apyx Medical
APYX
$126M
| $78.6K | ﹤0.01% |
27,276
+10,624
| +64% | +$31K |
|
|
BLU
11385
CALL
DELISTED
BELLUS Health Inc.
BLU
| $78.5K | ﹤0.01% |
10,900
-22,200
| -67% | -$172K |
|
11386
Foghorn Therapeutics
FHTX
$369M
| $78.5K | ﹤0.01% |
+12,657
| New | +$82.8K |
|
11387
MicroCloud Hologram
HOLO
$43.3M
| $78.4K | ﹤0.01% |
+4
| New | +$142K |
|
11388
Applied Optoelectronics
AAOI
$9.62B
| $78.1K | ﹤0.01% |
35,359
-24,791
| -41% | -$60.7K |
|
11389
PUT
Precigen
PGEN
$2.57B
| $78K | ﹤0.01% |
73,600
+62,800
| +581% | +$90.5K |
|
|
ADIL
11390
Adial Pharmaceuticals
ADIL
$16.7M
| $77.8K | ﹤0.01% |
356
+210
| +144% | +$50.9K |
|
11391
Harvard Bioscience
HBIO
$36M
| $77.8K | ﹤0.01% |
1,851
+446
| +32% | +$13.2K |
|
11392
DB Gold Double Short ETN due Feb 15 2038
DZZ
$2.97M
| $77.8K | ﹤0.01% |
+32,637
| New | +$84K |
|
11393
CALL
ProPetro Holding
PUMP
$1.37B
| $77.7K | ﹤0.01% |
10,800
-14,000
| -56% | -$127K |
|
|
PNNT
11394
PUT
Pennant Park Investment Corp
PNNT
$244M
| $77.6K | ﹤0.01% |
+14,700
| New | +$83.3K |
|
11395
Cemex
CX
$15.8B
| $77.5K | ﹤0.01% |
14,015
-66,826
| -83% | -$340K |
|
11396
CALL
Alector
ALEC
$267M
| $77.4K | ﹤0.01% |
12,500
-143,100
| -92% | -$1.16M |
|
|
AMTD
11397
AMTD IDEA Group
AMTD
$73.2M
| $77.3K | ﹤0.01% |
16,407
-14,180
| -46% | -$69.9K |
|
|
BURU
11398
PUT
DELISTED
NUBURU INC
BURU
| $77.2K | ﹤0.01% |
145
-2,226
| -94% | -$2.78M |
|
11399
PUT
Acco Brands
ACCO
$396M
| $77.1K | ﹤0.01% |
14,500
-8,300
| -36% | -$47.5K |
|
11400
Team
TISI
$110M
| $77K | ﹤0.01% |
+14,053
| New | +$107K |
|
Similar funds
Jeff Yass's Q1 2023 Portfolio in Review
As of Q1 2023, Jeff Yass held 14,310 positions worth $470B, up 19% from $395B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Jeff Yass's Q1 2023 filing shows 2,075 new, 5,756 increased, 4,471 reduced and 1,856 closed positions. Its largest new stake was Schwab US Aggregate Bond ETF: 2,949,950 shares worth $69.2M. The largest sale was Tesla, an estimated $1.62B.
By sector, the portfolio is most concentrated in Miscellaneous at 90% of assets, down from 91% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q1 2023 buy was Schwab US Aggregate Bond ETF: 2,949,950 shares worth $69.2M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $1.22B increase.
- Jeff Yass's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.62B.
- Jeff Yass fully exited NextEra Energy, Inc. 5.279% Corporate Units in Q1 2023, selling an estimated $61.5M.
- Jeff Yass's ten largest holdings make up 30% of its $470B portfolio in Q1 2023.
- Jeff Yass opened 2,075 new positions and closed 1,856 in Q1 2023.
- Jeff Yass's portfolio value rose 19% quarter-over-quarter to $470B.
Based on Susquehanna International Group's 13F filing for Q1 2023, filed 16 May 2023.